BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19

• Press Releases

  OmniAb to Hold OmniUltra Virtual Investor Event on December 15

  December 5, 2025

   · 

  2 min read
• Press Releases

  Protara Announces Pricing of $75 Million Public Offering

  December 5, 2025

   · 

  4 min read
• Press Releases

  Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL)

  December 5, 2025

   · 

  19 min read
• Press Releases

  ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical Mutations at the ESMO Asia Congress 2025

  December 5, 2025

   · 

  8 min read
• Press Releases

  ORIC® Pharmaceuticals Presents Enozertinib Data in NSCLC Patients with HER2 Exon 20 Mutations at the ESMO Asia Congress 2025

  December 5, 2025

   · 

  6 min read
• Press Releases

  ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting

  December 5, 2025

   · 

  4 min read
• Press Releases

  Ossium Health to Present New Clinical Data on Its Organ Donor Bone Marrow at ASH 2025

  December 5, 2025

   · 

  2 min read
• Press Releases

  Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock

  December 5, 2025

   · 

  5 min read
• Press Releases

  Cantargia Provides Update on Overall Survival Data from TRIFOUR

  December 5, 2025

   · 

  5 min read
• Press Releases

  Immatics Announces $125 Million Underwritten Offering

  December 5, 2025

   · 

  3 min read